|
|||||
|
|
Metformin use is associated with a decrease in the risk of hospitalization and mortality in COVID-19 patients with diabetes: A population-based study in Lombardy |
|
| Authors: | Luisa Ojeda-Fernández PhD Andreana Foresta MSc Giulia Macaluso MSc Pierluca Colacioppo MSc Mauro Tettamanti MSc Antonella Zambon MSc Stefano Genovese MD Ida Fortino MSc Olivia Leoni MSc Maria Carla Roncaglioni MSc Marta Baviera Pharm Dr |
| Affiliation: | 1. Laboratory of Cardiovascular Prevention, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy;2. Laboratory of Geriatric Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy;3. Department of Statistics and Quantitative Methods, University of Milano Bicocca, Milan, Italy;4. Centro Cardiologico Monzino IRCCS, Milan, Italy;5. Unità Organizzativa Osservatorio Epidemiologico Regionale, Lombardy Region, Milan, Italy |
| Abstract: | |
| Keywords: | COVID-19 diabetes metformin outcomes |
